PHARMACOLOGY
PROCTORED
EXAM
(NGN-STYLE QUESTIONS & CASE
“SCENARIO”)
Actual Qs & Ans to Pass the Exam
,This ATI test contains:
Passing Score Guarantee
Exam has 70 PHARMACOLOGY nursing
questions
multiple-choice format (A, B, C, D) with correct answers
structured rationales.
incorporate Next Generation NCLEX (NGN)-style.
Some questions feature brief “scenario” elements and
rationales.
,1. A nurse is reviewing the medication administration record of a
client who has an NG tube. Which of the following medications
should the nurse plan to administer through the NG tube?
A. Lovastatin
B. Warfarin
C. Metoprolol
D. Furosemide
Answer: C. Metoprolol
Expert Rationale:
Lovastatin tablets are extended-release formulations that should not be
crushed and administered via NG tube due to alteration of drug absorption
and effect. Metoprolol tablets can be crushed and safely given via NG tube.
The nurse must know which medications can be crushed or administered
through feeding tubes without affecting their efficacy or safety. Warfarin and
furosemide can be crushed if prescribed, but specific instructions must be
followed.
---
2. A nurse is collecting data from a client who is taking lithium
carbonate to treat bipolar disorder. For which of the following
findings should the nurse monitor and report to the provider?
A. Fine tremor
B. Constipation
, C. Hypotension
D. Bradycardia
Answer: A. Fine tremor
Expert Rationale:
Tremors can be an early sign of lithium toxicity and should always be
monitored. Lithium has a narrow therapeutic window, and manifestations like
tremor, confusion, or gastrointestinal upset require prompt evaluation.
Constipation, hypotension, and bradycardia are not primary adverse effects
of lithium.
---
3. A nurse is caring for a client who has prescriptions for
spironolactone and lisinopril. The nurse should monitor for which of
the following adverse effects?
A. Hypokalemia
B. Hyperkalemia
C. Hyponatremia
D. Hypocalcemia
Answer: B. Hyperkalemia
Expert Rationale:
Both spironolactone (a potassium-sparing diuretic) and lisinopril (an ACE
inhibitor) can increase serum potassium levels, increasing the risk of
hyperkalemia, which can cause cardiac arrhythmias. Monitoring potassium
levels is essential when these drugs are combined.